To date, BPC-157 has reportedly been studied in a small number of human trials, including two early-stage trials for ulcerative colitis, but full results have not been published in a peer-reviewed journal
Recommended For You FDA Peptide Decision 2026: The Final Vote on BPC-157, TB-500, MOTS-c and More What It Means for You Across July 2324, 2026, the FDA's advisory committee recommended six peptides for legal compounding BPC-157, KPV, TB-500, MOTS-c, epitalon, and Semax and rejected one, emideltide (DSIP)
We also go beyond the research, interviewing top experts in their fields to bring you the most informed insights
A melanocortin peptide, PT 141, activates melanocortin receptors in the brain
Benzyl alcohol suppresses bacterial growth but does not eliminate it indefinitely